Cite
HARVARD Citation
Guadagnolo, B. et al. (2022). Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet oncology. 23 (12), pp. 1547-1557. [Online].